Table 2.
PPV | NPV | Sensitivity | Specificity | |
---|---|---|---|---|
High volume | ||||
| ||||
Intravitreal Injection | 97.5% | 99.5% | 99.3% | 98.3% |
Focal Laser | 100% | 99.7% | 94.1% | 100% |
Panretinal Photocoagulation | 100% | 99.8% | 97.9% | 100% |
Ranibizumab | 90.5% | 99.6% | 98.6% | 97.2% |
Bevacizumab | 89.5% | 99.4% | 96.9% | 98.0% |
Fundus Photography | 94.1% | 99.5% | 92.8% | 99.6% |
Fluorescein Angiography | 96.7% | 99.7% | 96.7% | 99.7% |
Optical Coherence Tomography | 97.7% | 94.7% | 96.3% | 96.7% |
Procedure Laterality | 99.0% | 88.6% | 87.6% | 99.1% |
| ||||
Low volume | ||||
| ||||
Aflibercept | 100% | 100% | 100% | 100% |
Triamcinolone | 100% | 99.9% | 88.9% | 100% |
Dexamethasone implant | 100% | 100% | 100% | 100% |
Subtenons Injection | 100% | 99.7% | 40.0% | 100% |
B-scan Ultrasound | 69.6% | 99.9% | 94.1% | 99.3% |